| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/29/2004 | US20040082631 Pyrazole compositions useful as inhibitors of ERK |
| 04/29/2004 | US20040082630 1g(a)-Amino-n-hydroxy-acetamide derivatives |
| 04/29/2004 | US20040082627 Certain aromatic monocycles as kinase modulators |
| 04/29/2004 | US20040082623 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/29/2004 | US20040082602 Kinase inhibitor; analgesics; antiarthritic agents; antihistamines; gastrointestinal disorders |
| 04/29/2004 | US20040082595 Antiproliferative agents; antitumor agents; cyclin-dependent kinase inhibitor |
| 04/29/2004 | US20040082584 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 04/29/2004 | US20040082583 Chemical compounds |
| 04/29/2004 | US20040082581 Controlling cell proliferation; antitumor agents |
| 04/29/2004 | US20040082576 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/29/2004 | US20040082575 Compounds and methods for modulation of estrogen receptors |
| 04/29/2004 | US20040082569 Novel substituted amides, their preparation and use |
| 04/29/2004 | US20040082567 Antiproliferative agents; anticancer agents; fungicides; antiinflammatory agents |
| 04/29/2004 | US20040082564 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 04/29/2004 | US20040082563 Thrombosis therapy; antitumor agents; anticoagulants; Factor x inhibitors; anticholesterol agents; cardiovascular disorders; antiinflammatory agents |
| 04/29/2004 | US20040082562 Novel inhibitors of IMPDH enzyme |
| 04/29/2004 | US20040082556 Inhibitors of type 5 and type 3 17beta-hydroxysteroid dehydrogenase and methods for their use |
| 04/29/2004 | US20040082551 Novel pyrazoles and their use as p38 kinase inhibitors |
| 04/29/2004 | US20040082550 Tropolone derivative |
| 04/29/2004 | US20040082548 Cardiovascular disorders; Alzheimer's disease; anticholesterol agents |
| 04/29/2004 | US20040082547 Prevent thrombosis; anticholesterol agents; cardiovascular disorders; anticancer agents |
| 04/29/2004 | US20040082542 Useful as modulators of interaction between receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, beta-amyloid and amphoterin |
| 04/29/2004 | US20040082531 Containing a transcription regulatory sequence derived from Human Cytomegalovirus major immediate early gene that includes exon 1, but not intron A; use of such vectors in vaccine and pharmaceutical compositions and gene therapy |
| 04/29/2004 | US20040082529 Treating or preventing cancer by administering to subject a vector comprising a heterologous polynucleotide operably linked to one or more regulatory sequences derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence |
| 04/29/2004 | US20040082528 Pulsatillae radix root is known to have effects of removing heat from the blood and detoxifying; it has also been used as antiinflammatory, astringent, hemostatic and antidiarrhea agents |
| 04/29/2004 | US20040082517 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/29/2004 | US20040082512 Drugs for treatment of inflammation/blood brain barrier degradation |
| 04/29/2004 | US20040082510 Pyk2 phosphorylation by her3 induces tumor invasion |
| 04/29/2004 | US20040082507 Use of GLP-1 and GLP-2 peptides |
| 04/29/2004 | US20040082506 For treating hypophosphatemic rickets/osteomalacia/ osteoporosis/renal osteodystrophy/dialysis-associated bone diseases |
| 04/29/2004 | US20040082504 Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 04/29/2004 | US20040082499 Perturbed membrane-binding compounds |
| 04/29/2004 | US20040082065 Cascading priming cells; stimulating lymphocytes; incubation |
| 04/29/2004 | US20040082054 Novel depsipeptide compound |
| 04/29/2004 | US20040081976 Genomic screen for epigenetically silenced tumor suppressor genes |
| 04/29/2004 | US20040081972 Detecting antibodies; screening, development therapies for infections, inflammation; polypeptides; monoclonal antibodies |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081734 Obtaining a balanced enriched composition of simple phenols, polyphenols, bioflavonoids, flavones and flavonones, to control oxidation processes, from citrus aqueous extracts |
| 04/29/2004 | US20040081689 Activating a fluid ejector actuator to eject a bioactive fluid onto at least a portion of an interior surface of said enclosing medium |
| 04/29/2004 | US20040081688 Comprising a drug, a lipid matrix and a surfactant characterized in that said drug is a peptide or a protein and lipid matrix has a monoglyceride content which is at least 70% w/w |
| 04/29/2004 | US20040081686 Use of particle vectors in immunomodulation |
| 04/29/2004 | US20040081673 Compositions and methods for the treatment of skin damage |
| 04/29/2004 | US20040081654 Use of plant oil-bodies in vaccine delivery systems |
| 04/29/2004 | US20040081636 Genetic engineering; polynucleotides |
| 04/29/2004 | US20040081635 Antiinflammatory agents; anticancer agents; bactericides; fungicides; autoimmune diseases; mixture of interferons with carriers |
| 04/29/2004 | US20040081617 Ferrites labeled with radioactive material; medical trancers; imaging therapy |
| 04/29/2004 | DE10294485T5 Mit Mnk-Kinase homologe Proteine, die in die Regulation der Energiehomöostase und den Organellenmetabolismus involviert sind Mnk homologous proteins with kinase, that are involved in the regulation of energy homeostasis and the metabolism organelle |
| 04/29/2004 | CA2783175A1 Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives |
| 04/29/2004 | CA2515650A1 New adenoviruses, nucleic acids coding therefor and their use |
| 04/29/2004 | CA2502515A1 Pyrrolo (3,4-c) carbazole and pyrido (2,3-b) pyrrolo (3,4-e) indole derivatives, preparation method and pharmaceutical compositions containing same |
| 04/29/2004 | CA2502211A1 Azo compounds for type i phototherapy |
| 04/29/2004 | CA2501556A1 Remedy for hormone-dependent cancer |
| 04/29/2004 | CA2501418A1 Novel compounds |
| 04/29/2004 | CA2501333A1 Factor involved in metastasis and uses thereof |
| 04/29/2004 | CA2501265A1 Inhibitors of histone deacetylase |
| 04/29/2004 | CA2497262A1 Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 04/28/2004 | EP1413582A1 Dimeric pyrrolobenzodiazepines |
| 04/28/2004 | EP1413581A1 Rapamycin derivatives |
| 04/28/2004 | EP1413434A1 Pharmaceutical dosage form and method of making |
| 04/28/2004 | EP1413315A1 Sustained-release medicines |
| 04/28/2004 | EP1413302A2 Substituted guanidines for the treatment of pain |
| 04/28/2004 | EP1413300A1 Pyrimidinium-guanidiniminoethylphenyl-guanidinoalkyl-amines and guanidiniminoethylphenyl-guanidinoalkylamines as pharmaceutically active new substances |
| 04/28/2004 | EP1412754A1 Diagnostic methods and agents |
| 04/28/2004 | EP1412748A2 Mage-a3 peptides presented by hla class ii molecules |
| 04/28/2004 | EP1412498A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 04/28/2004 | EP1412492A2 Regulator of calcineurin |
| 04/28/2004 | EP1412485A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 04/28/2004 | EP1412477A2 GPCs AS MODIFIERS OF THE IRRTK AND P21 PATHWAYS AND METHODS OF USE |
| 04/28/2004 | EP1412389A1 Binding agents with differential activity |
| 04/28/2004 | EP1412388A1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 04/28/2004 | EP1412383A2 Peptides conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri) |
| 04/28/2004 | EP1412377A1 Production of high molecular mass lectins |
| 04/28/2004 | EP1412374A2 Novel pgc-1 isoforms and uses therefor |
| 04/28/2004 | EP1412371A1 IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING |
| 04/28/2004 | EP1412370A1 Nucleoside pyrophosphate and triphosphate analogs and related compounds as therapeutic agents |
| 04/28/2004 | EP1412363A1 Gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1412357A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/28/2004 | EP1412338A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1412332A1 Quinoline derivatives and use thereof as antitumor agents |
| 04/28/2004 | EP1412330A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/28/2004 | EP1412328A1 Dolastatin 10 derivatives |
| 04/28/2004 | EP1412327A2 Inhibitors of protein kinase for the treatment of disease |
| 04/28/2004 | EP1412322A2 Protected 3.5-dihydroxy-2.2-dimethyl-valeroamides for the synthesis of epothilone and derivatives and method for the production and use thereof |
| 04/28/2004 | EP1412320A1 Linked cyclitols and their polysulfated derivatives |
| 04/28/2004 | EP1412317A1 Retinoid derivatives with antiangiogenic, antitumor and proapoptotic activities |
| 04/28/2004 | EP1412311A1 Novel treatment of adrenocortical hypersecretion and tumour growth |
| 04/28/2004 | EP1412029A2 Combinations comprising epothilones and pharmaceutical uses thereof |
| 04/28/2004 | EP1411994A2 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formation |
| 04/28/2004 | EP1411993A2 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 04/28/2004 | EP1411987A2 Targeted polymeric delivery systems |
| 04/28/2004 | EP1411986A1 Composition for epigallocatechin gallate |
| 04/28/2004 | EP1411984A2 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 04/28/2004 | EP1411983A1 Bispecific antibodies that bind to vegf receptors |
| 04/28/2004 | EP1411982A1 Modulators of p-selectin glycoprotein ligand 1 |
| 04/28/2004 | EP1411980A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 04/28/2004 | EP1411974A2 Materials and methods relating to improved vaccination strategies |
| 04/28/2004 | EP1411963A2 Cytotoxic factors for modulating cell death |
| 04/28/2004 | EP1411962A2 Monoclonal antibody therapy for pancreas cancer |
| 04/28/2004 | EP1411954A2 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 04/28/2004 | EP1411953A1 Methods and compositions for treatment of gastric diseases |